Influence of 4‐week or 12‐week glucocorticoid treatment on metabolic changes in patients with active moderate‐to‐severe thyroid‐associated ophthalmopathy
Abstract Thyroid‐associated ophthalmopathy (TAO) is a serious, progressive, vision‐threatening and difficult‐to‐treat organ‐specific autoimmune disease. The course, therapeutic effects and prognosis of moderate to severe TAO vary greatly. High‐dose intravenous glucocorticoid (IVGC) therapy is consid...
Saved in:
Main Authors: | Xiaoman Chen (Author), Buatikamu Abudukerimu (Author), Qin Li (Author), Qing Li (Author), Jie Qiao (Author), Dongping Lin (Author), Chunhua Sui (Author), Lin Ye (Author), Hualing Zhai (Author), Boren Jiang (Author), Ningjian Wang (Author), Mengda Jiang (Author), Xiaofeng Tao (Author), Ziyang Shao (Author), Chenfang Zhu (Author), Yubo Ma (Author), Ping Xiong (Author), Jing Sun (Author), Huifang Zhou (Author), Bing Han (Author), Yingli Lu (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Graves' ophthalmopathy - thyroid eye disease
by: Dagna Siedlecka, et al.
Published: (2019) -
Treatment of ophthalmopathy in the course of Graves' disease
by: Magdalena Woźniak, et al.
Published: (2019) -
Treatment of ophthalmopathy in the course of Graves' disease
by: Magdalena Woźniak, et al.
Published: (2019) -
Graves' ophthalmopathy - thyroid eye disease
by: Dagna Siedlecka, et al.
Published: (2019) -
Precision Medicine in Graves' Disease and Ophthalmopathy
by: Giusy Elia, et al.
Published: (2021)